Article Details

Maxion Therapeutics: £58 Million (Series A) Closed For Developing KnotBody Drugs For Ion ...

Retrieved on: 2025-03-18 03:21:33

Tags for this article:

Click the tags to see associated articles and topics

Maxion Therapeutics: £58 Million (Series A) Closed For Developing KnotBody Drugs For Ion .... View article details on hiswai:

Excerpt

Following the funding, Elena Viboch, Managing Director at General Catalyst and Emma Johnson, Senior Investment Manager, Life Sciences at British ...

Article found on: pulse2.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo